NASDAQ: NXLNexalin Technology Inc Stock Ownership - Who owns Nexalin Technology?
Insider buying vs selling
Have Nexalin Technology Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Carolyn Hamby Shelton | Sr. VP - Quality Regulatory | 2025-03-12 | 6,000 | $2.20 | $13.20kBuy |
| David Owens | Chief Medical Officer | 2025-02-04 | 1,000 | $2.98 | $2.98kBuy |
| David Owens | Chief Medical Officer | 2025-02-04 | 1,000 | $3.10 | $3.10kBuy |
| David Owens | Chief Medical Officer | 2025-01-28 | 1,500 | $2.70 | $4.05kBuy |
| David Owens | Chief Medical Officer | 2025-01-23 | 1,000 | $2.70 | $2.70kBuy |
| David Owens | Chief Medical Officer | 2025-01-13 | 2,000 | $2.50 | $5.00kBuy |
NXL insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NXL insiders and whales buy or sell their stock.
NXL Shareholders
What type of owners hold Nexalin Technology Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Marilyn Elson | 12.71% | 2,370,488 | $1.64M | Insider |
| Leonard Osser | 8.68% | 1,618,577 | $1.12M | Insider |
| Ben Hu | 2.04% | 381,261 | $263.83k | Insider |
| Mark White | 1.52% | 284,127 | $196.62k | Insider |
| David Owens | 1.03% | 191,252 | $132.35k | Insider |
| Vanguard Group Inc | 0.95% | 176,582 | $122.19k | Institution |
| Rick Morad | 0.90% | 167,626 | $116.00k | Insider |
| Myda Advisors LLC | 0.80% | 150,000 | $103.80k | Institution |
| Geode Capital Management LLC | 0.65% | 121,820 | $84.30k | Institution |
| Alan Kazden | 0.64% | 119,590 | $82.76k | Insider |
NXL vs Medical Device Stocks
Nexalin Technology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.